CN108842119A - 一种表面镀有纳米碳晶膜的人体植入材料及其制备方法 - Google Patents
一种表面镀有纳米碳晶膜的人体植入材料及其制备方法 Download PDFInfo
- Publication number
- CN108842119A CN108842119A CN201810763459.5A CN201810763459A CN108842119A CN 108842119 A CN108842119 A CN 108842119A CN 201810763459 A CN201810763459 A CN 201810763459A CN 108842119 A CN108842119 A CN 108842119A
- Authority
- CN
- China
- Prior art keywords
- magnesium alloy
- nano
- preparation
- sized carbon
- coated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title claims abstract description 60
- 229910052799 carbon Inorganic materials 0.000 title claims abstract description 48
- 239000000463 material Substances 0.000 title claims abstract description 48
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 229910000861 Mg alloy Inorganic materials 0.000 claims abstract description 59
- MTPVUVINMAGMJL-UHFFFAOYSA-N trimethyl(1,1,2,2,2-pentafluoroethyl)silane Chemical compound C[Si](C)(C)C(F)(F)C(F)(F)F MTPVUVINMAGMJL-UHFFFAOYSA-N 0.000 claims abstract description 23
- 238000010438 heat treatment Methods 0.000 claims abstract description 18
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000010936 titanium Substances 0.000 claims abstract description 17
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 17
- 230000007704 transition Effects 0.000 claims abstract description 15
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000011777 magnesium Substances 0.000 claims abstract description 14
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 14
- 238000010791 quenching Methods 0.000 claims abstract description 9
- 230000000171 quenching effect Effects 0.000 claims abstract description 9
- 238000005516 engineering process Methods 0.000 claims abstract description 8
- 229910052751 metal Inorganic materials 0.000 claims abstract description 6
- 239000002184 metal Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 24
- 235000019441 ethanol Nutrition 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000013078 crystal Substances 0.000 claims description 14
- 229910002804 graphite Inorganic materials 0.000 claims description 12
- 239000010439 graphite Substances 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- 238000003763 carbonization Methods 0.000 claims description 8
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 7
- 239000000908 ammonium hydroxide Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- FPCJKVGGYOAWIZ-UHFFFAOYSA-N butan-1-ol;titanium Chemical compound [Ti].CCCCO.CCCCO.CCCCO.CCCCO FPCJKVGGYOAWIZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000002604 ultrasonography Methods 0.000 claims description 6
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 4
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 claims description 4
- 229920003081 Povidone K 30 Polymers 0.000 claims description 4
- 230000001133 acceleration Effects 0.000 claims description 4
- 238000013019 agitation Methods 0.000 claims description 4
- 238000007605 air drying Methods 0.000 claims description 4
- 238000005282 brightening Methods 0.000 claims description 4
- 229920002301 cellulose acetate Polymers 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 238000001962 electrophoresis Methods 0.000 claims description 4
- 229940093430 polyethylene glycol 1500 Drugs 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 238000004528 spin coating Methods 0.000 claims description 4
- 238000004506 ultrasonic cleaning Methods 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims 1
- 239000004576 sand Substances 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 238000005260 corrosion Methods 0.000 description 19
- 230000007797 corrosion Effects 0.000 description 19
- 239000000243 solution Substances 0.000 description 18
- 206010018910 Haemolysis Diseases 0.000 description 10
- 230000008588 hemolysis Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 7
- 239000003519 biomedical and dental material Substances 0.000 description 5
- 238000000151 deposition Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000002513 implantation Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000012890 simulated body fluid Substances 0.000 description 5
- 230000006399 behavior Effects 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 244000137852 Petrea volubilis Species 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000008279 sol Substances 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 229910001566 austenite Inorganic materials 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22F—CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
- C22F1/00—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
- C22F1/06—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working of magnesium or alloys based thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/024—Carbon; Graphite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/082—Inorganic materials
- A61L31/084—Carbon; Graphite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/082—Inorganic materials
- A61L31/088—Other specific inorganic materials not covered by A61L31/084 or A61L31/086
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22F—CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
- C22F1/00—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
- C22F1/002—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working by rapid cooling or quenching; cooling agents used therefor
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C18/00—Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating
- C23C18/02—Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition
- C23C18/12—Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition characterised by the deposition of inorganic material other than metallic material
- C23C18/1204—Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition characterised by the deposition of inorganic material other than metallic material inorganic material, e.g. non-oxide and non-metallic such as sulfides, nitrides based compounds
- C23C18/1208—Oxides, e.g. ceramics
- C23C18/1216—Metal oxides
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C18/00—Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating
- C23C18/02—Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition
- C23C18/12—Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition characterised by the deposition of inorganic material other than metallic material
- C23C18/125—Process of deposition of the inorganic material
- C23C18/1254—Sol or sol-gel processing
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C18/00—Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating
- C23C18/02—Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition
- C23C18/12—Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition characterised by the deposition of inorganic material other than metallic material
- C23C18/125—Process of deposition of the inorganic material
- C23C18/1262—Process of deposition of the inorganic material involving particles, e.g. carbon nanotubes [CNT], flakes
- C23C18/127—Preformed particles
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C28/00—Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D
- C23C28/04—Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D only coatings of inorganic non-metallic material
- C23C28/042—Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D only coatings of inorganic non-metallic material including a refractory ceramic layer, e.g. refractory metal oxides, ZrO2, rare earth oxides
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D13/00—Electrophoretic coating characterised by the process
- C25D13/02—Electrophoretic coating characterised by the process with inorganic material
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D13/00—Electrophoretic coating characterised by the process
- C25D13/20—Pretreatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Metallurgy (AREA)
- Mechanical Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Thermal Sciences (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Ceramic Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Electrochemistry (AREA)
- Dispersion Chemistry (AREA)
- Nanotechnology (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种表面镀有纳米碳晶膜的人体植入材料及制备方法,所述人体植入材料通过采用梯度过渡层技术,以钛为过渡层元素,在硬质的纳米碳晶膜与软质金属镁之间引入梯度过渡层得到。本发明通过淬火热处理技术,改变镁合金内部的金相结构,从而提高了镁合金的硬度,通过淬火热处理,镁合金内部晶粒细化且分布更加均匀,耐腐性有一定提高,碳化钛作为过渡层具有良好的抗磨损性能、高的硬度、高的强度和刚度,还具有优良的抗裂纹形成能力,不易产生应力集中。同时,引入钛元素在促使应力释放的同时,还能够提高非晶碳膜的稳定性。
Description
技术领域
本发明属于生物医用材料技术领域,具体涉及一种表面镀有纳米碳晶膜的人体植入材料及其制备方法。
背景技术
镁合金,作为第三代生物医用人体植入材料,具有生物活性且人体自身可降解吸收,由于其降解产物是人体必须元素,可被人体吸收而排除体外,不会引起不良反应,可将其作为心血管支架材料,具有良好的力学性能和生物相容性。因此,镁作为生物医学材料不但具有可行性,而且具有经济意义和发展前景。
但是,镁的耐蚀性能较差,在氯离子存在或所在介质的pH值低于11.5时,镁的腐蚀速率更快。镁的腐蚀会导致氢气的产生,使周围环境碱化,恶化植入材料周围的环境,降低镁植入人体后的使用寿命,这些均不利于镁合金在人体内的应用。因此要将镁合金真正应用到生物医学材料当中,需要控制其腐蚀速度及析氢过程。
纳米碳晶具有硬度高、良好的耐磨损性能、化学惰性以及良好的生物相容性。将纳米碳晶与镁基体相结合,利用纳米碳晶的耐腐蚀性能,可减缓镁合金在体液中的腐蚀速率,并利用其良好的生物相容性,提高镁基体植入材料与人体的相容性。同时,纳米碳晶表面具有超疏水性,可以抑制血小板的粘附和血栓的形成。
发明内容
本发明的目的是提供一种表面镀有纳米碳晶膜的人体植入材料,同时提供其制备方法是本发明的又一发明目的。
为实现上述发明目的,本发明采取的技术方案为:
一种表面镀有纳米碳晶膜的人体植入材料,所述人体植入材料通过采用梯度过渡层技术,以钛为过渡层元素,在硬质的纳米碳晶膜与软质金属镁之间引入梯度过渡层得到。
所述的表面镀有纳米碳晶膜的人体植入材料的制备方法,包括以下步骤:
1)淬火热处理:镁合金试样依次经过酒精浸泡、无水乙醇清洗、氮气吹干后,将其放入马弗炉中快速升温至250℃保温1h后取出,放入水中,待试样达到室温后将其从水中取出,氮气吹干;其中,马弗炉升温速率为4-5℃/min。本申请中控制升温速率则直接影响形成的晶粒大小并最终影响镁合金质量,如升温速度过慢,淬火升温时间延长,会造成加热时形成的初始奥氏体晶核较大,后续保温过程中则会继续长大,导致淬火后的晶粒粗大;但是升温速度过快,奥氏体初始晶粒则会越细,在随后的保温过程中,其长大的倾向就越大,而更容易形成粗晶,造成金相结构不合格,从而影响镁合金质量。
2)碳化钛薄膜的制备:先将经过步骤1)热处理的镁合金试样依次用2000#、3000#的砂纸水磨至表面光亮无痕状态,酒精超声清洗,氮气吹干;
3)碳化钛溶液的制备:称取聚乙烯吡咯烷酮K30和聚乙二醇-1500各0.01-0.02g,加入9-10mL的去离子水混合,用氨水调节溶液的pH值为10,之后加入碳化钛纳米粉末0.25-0.35g,再用氨水调节溶液的pH值为10,将上述配好的溶液以20000-30000HZ的频率超声30-40min,再搅拌1-2h,搅拌采用磁力搅拌,搅拌的速度为1000-1500rpm;
4)碳化钛薄膜样片的制备:把镁合金片和石墨片浸入碳化钛溶液中,分别作为阴极和阳极,施加2.0V电压通电电泳3min后,将阴极镁合金片带电极取出,自然风干后在500-600℃焙烧1h即制得碳化钛薄膜样片;
4)将2-10g的纳米碳晶、30-40mL的乙醇和4-5mL的钛酸四丁酯混合,再加入10mL浓度为20mg/mL的乙酸纤维素混合形成溶胶,旋凃到经步骤4)处理的碳化钛薄膜样片上,于450-500℃下煅烧2-3h,即得。本发明中,加入纳米碳晶过少时,最终得到的产品耐腐蚀性不高,也减缓不了镁合金在体液中的腐蚀速率,同时不能提高镁基体植入材料与人体的生物相容性;加入量过多时,不利于膜的形成,膜表面容易出现空洞,膜的完整性不好,机械性能差,不能有效阻止溶液进入镁合金材料的内部,对基体提供不了良好的保护。
步骤1)中,镁合金试样的尺寸为1cm×1cm×0.5cm,酒精浸泡的时间为30-40min,无水乙醇清洗3-4次。
步骤4)中,镁合金片和石墨片的表面积相同,镁合金片和石墨片二者的距离为7-9cm。
步骤5)中,先称取纳米碳晶2-10g,加入到30-40mL的乙醇中,再向其中加入4-5mL的钛酸四丁酯。
步骤5)中,旋凃采用的旋涂仪参数设置:转速为300-400r/min-60s,加速度为2500-3000r/min-30s。
本发明通过淬火热处理技术,改变镁合金内部的金相结构,从而提高了镁合金的硬度,通过淬火热处理,镁合金内部晶粒细化且分布更加均匀,耐腐性有一定提高,碳化钛作为过渡层具有良好的抗磨损性能、高的硬度、高的强度和刚度,还具有优良的抗裂纹形成能力,不易产生应力集中。同时,引入钛元素在促使应力释放的同时,还能够提高非晶碳膜的稳定性。
与现有技术相比,本发明具有以下优点:
1、在镁合金表面沉积纳米碳晶膜,有效的缓解模拟体液对镁合金的腐蚀,由于硬质膜与软质金属之间膨胀系数的不同导致两者的结合力非常小,在膜与基体之间引入过渡层,可有效的提高两者之间的结合力;
2、以钛为过渡层元素,在镁合金表面沉积纳米碳晶膜,通过静态接触角表明,膜具有超疏水性,有效的阻止了模拟体液进入膜的内部,减少了镁合金的腐蚀;
3、溶血率实验表明,所得纳米碳晶膜溶血率<5%,材料复合生物医用材料溶血率要求,具有生物相容性。
附图说明
图1不同处理的镁合金腐蚀速率。
具体实施方式
以下采用具体实施方式对本发明做进一步说明。
实施例1
一种表面镀有纳米碳晶膜的人体植入材料,所述人体植入材料通过采用梯度过渡层技术,以钛为过渡层元素,在硬质的纳米碳晶膜与软质金属镁之间引入梯度过渡层得到。
所述的表面镀有纳米碳晶膜的人体植入材料的制备方法,包括以下步骤:
1)淬火热处理:镁合金试样(本实施例中选用挤压态AZ31B镁合金为材料,尺寸为1cm×1cm×0.5cm)依次经过酒精浸泡30min、无水乙醇清洗3次(浸泡清洗的目的是除去表面的油垢)、氮气吹干后,先放入恒温真空室中待用;将其放入马弗炉中快速升温至250℃保温1h后取出,放入水中,待试样达到室温后将其从水中取出,氮气吹干,(放在恒温真空室中待用;其中,马弗炉升温速率为4℃/min;
2)碳化钛薄膜的制备:先将经过步骤1)热处理的镁合金试样依次用2000#、3000#的砂纸水磨至表面光亮无痕状态,酒精超声清洗(去除表面污垢),氮气吹干(将试样表面的酒精吹干),放在干燥的恒温干燥室中备用;
3)碳化钛溶液的制备:称取聚乙烯吡咯烷酮K30和聚乙二醇-1500各0.01g,加入9mL的去离子水混合,用氨水调节溶液的pH值为10,之后加入碳化钛纳米粉末0.25g,再用氨水调节溶液的pH值为10,将上述配好的溶液以20000HZ的频率超声40min,再搅拌1h,搅拌采用磁力搅拌,搅拌速度为1500rpm;超声和搅拌的目的是使粉末充分分散;
4)碳化钛薄膜样片的制备:把镁合金片和石墨片浸入碳化钛溶液中,分别作为阴极和阳极,其中,镁合金片和石墨片的表面积相同,镁合金片和石墨片二者的距离为7-9cm,施加2.0V电压通电电泳3min后,将阴极镁合金片带电极取出,自然风干后在500-600℃焙烧1h即制得碳化钛薄膜样片;
5)先称取纳米碳晶2g,加入到30mL的乙醇中,再向其中加入4mL的钛酸四丁酯,再加入10mL浓度为20mg/mL的乙酸纤维素混合形成溶胶,旋凃到经步骤4)处理的碳化钛薄膜样片上,于500℃下煅烧2h,即得;旋凃采用的旋涂仪参数设置为转速为300-400r/min-60s,加速度为2500-3000r/min-30s。
实施例2
一种表面镀有纳米碳晶膜的人体植入材料,所述人体植入材料通过采用梯度过渡层技术,以钛为过渡层元素,在硬质的纳米碳晶膜与软质金属镁之间引入梯度过渡层得到。
所述的表面镀有纳米碳晶膜的人体植入材料的制备方法,包括以下步骤:
1)淬火热处理:镁合金试样(本实施例中选用挤压态AZ31B镁合金为材料,尺寸为1cm×1cm×0.5cm)依次经过酒精浸泡40min、无水乙醇清洗4次(浸泡清洗的目的是除去表面的油垢)、氮气吹干后,先放入恒温真空室中待用;将其放入马弗炉中快速升温至250℃保温1h后取出,放入水中,待试样达到室温后将其从水中取出,氮气吹干,(放在恒温真空室中待用;其中,马弗炉升温速率为5℃/min;
2)碳化钛薄膜的制备:先将经过步骤1)热处理的镁合金试样依次用2000#、3000#的砂纸水磨至表面光亮无痕状态,酒精超声清洗(去除表面污垢),氮气吹干(将试样表面的酒精吹干),放在干燥的恒温干燥室中备用;
3)碳化钛溶液的制备:称取聚乙烯吡咯烷酮K30和聚乙二醇-1500各0.02g,加入10mL的去离子水混合,用氨水调节溶液的pH值为10,之后加入碳化钛纳米粉末0.35g,再用氨水调节溶液的pH值为10,将上述配好的溶液以30000HZ的频率超声30min,再搅拌2h,采用磁力搅拌,搅拌速度为1000rpm,超声和搅拌的目的是使粉末充分分散;
4)碳化钛薄膜样片的制备:把镁合金片和石墨片浸入碳化钛溶液中,分别作为阴极和阳极,其中,镁合金片和石墨片的表面积相同,镁合金片和石墨片二者的距离为9cm,施加2.0V电压通电电泳3min后,将阴极镁合金片带电极取出,自然风干后在600℃焙烧1h即制得碳化钛薄膜样片;
5)先称取纳米碳晶10g,加入到40mL的乙醇中,再向其中加入5mL的钛酸四丁酯,再加入10mL浓度为20mg/mL的乙酸纤维素混合形成溶胶,旋凃到经步骤4)处理的碳化钛薄膜样片上,于500℃下煅烧2h,即得;旋凃采用的旋涂仪参数设置为转速为300-400r/min-60s,加速度为2500-3000r/min-30s。
实施例3
一种表面镀有纳米碳晶膜的人体植入材料及其制备方法,与实施例1不同之处在于,
步骤5)中纳米碳晶6g。其余同实施例1。
性能测试:
为说明发明效果,本发明以实施例1所制得的人体植入材料为例对其进行了腐蚀速率、接触角及溶血性进行了相关测试。
1、腐蚀速率比较
本实验数据是通过失重实验所得到的,因为镁合金腐蚀过程中会有氢气产生,每天对反应体系称重,记录体系损失的重量,通过析出氢气体系的减少量来评价镁合金的腐蚀速率。结果如图1所示。
由图1的结果可知,与表面沉积纳米碳晶膜的镁合金相比较,没有沉积纳米碳晶膜的镁合金腐蚀速率明显的比沉积了纳米碳晶膜的镁合金腐蚀速率要大,其变化趋势波动比较大。沉积了纳米碳晶膜的镁合金,腐蚀速率明显非常小,变化趋势比较稳定,始终维持在一个相对比较低的水平。通过比较可知,镁合金表面沉积纳米碳晶膜之后腐蚀速率明显减小。
2、接触角
当静态接触角大于90°小于120°时,材料具有疏水性,当接触角大于120°时,材料具有超疏水性。从静态接触角的测试结果表1来看,在沉积纳米碳晶之后镁合金的疏水性明显提高,其接触角为132°,具有超疏水性,而未经处理的镁合金的接触角为76°。由此可见,以碳化钛为过渡层得到的纳米碳晶膜对基体的保护效果较好,此实验结果与其腐蚀速率结果是一致的,这可使溶液更难进入到镁合金表面,更能进一步提高镁合金的耐腐蚀性。
表1不同样品接触角的比较
3、溶血实验
对人体植入材料而言,当异种材料植入人体后,人体会发生排异反应,所以在植入之前应该对材料的生物活性进行表征。其中最重要的就是溶血实验,当材料在模拟体液中发生一定量的溶血,则材料不能植入人体当中。具体标准为:当材料的溶血率<5%,则说明材料符合生物医用材料的溶血率要求。如果材料的溶血率>5%,则预示材料有溶血作用,材料不能植入到人体当中,此材料部具有生物相容性。
本实验选用未经任何处理的镁合金(阴性对照组)、空白对照组和经过制备以钛为过渡层元素沉积纳米碳晶膜(实验组)作为实验所用的材料。首先阴性对照试管3支,各加入6mL模拟体液;空白对照试管3支,各加入6mL蒸馏水;待测样品装入3支试管。然后将全部试管放入37±0.5℃恒温培养箱保温60min;取新鲜兔血3mL,加入20g/L草酸钾0.1mL,摇晃均匀后加入3mL的模拟体液稀释待用;将空白组各试管中加入稀释后的兔血200μL,轻轻摇匀。最后将全部试管放入37±0.5℃恒温培养箱保温60min。取出试管,将试管内的溶液以4000r/min的速度离心10min,取上层清液,用分管光度计测量,在波长545nm处读数计算溶血率。
表2溶血率测试结果
从表2可以明显看出,未经任何处理的阴性对照组溶血率达到了63.18%,显然材料不符合植入人体的标准。在镁基体的表面沉积纳米碳晶膜后实验组样品的溶血率<5%,符合植入人体的条件,说明纳米碳晶具有生物相容性。
Claims (6)
1.一种表面镀有纳米碳晶膜的人体植入材料,其特征在于,所述人体植入材料通过采用梯度过渡层技术,以钛为过渡层元素,在硬质的纳米碳晶膜与软质金属镁之间引入梯度过渡层得到。
2.权利要求1所述的表面镀有纳米碳晶膜的人体植入材料的制备方法,其特征在于,包括以下步骤:
1)淬火热处理:镁合金试样依次经过酒精浸泡、无水乙醇清洗、氮气吹干后,将其放入马弗炉中快速升温至250℃保温 1h后取出,放入水中,待试样达到室温后将其从水中取出,氮气吹干;
2)碳化钛薄膜的制备:先将经过步骤1)热处理的镁合金试样依次用2000#、3000#的砂纸水磨至表面光亮无痕状态,酒精超声清洗,氮气吹干;
3)碳化钛溶液的制备:称取聚乙烯吡咯烷酮K30和聚乙二醇-1500各0.01-0.02g,加入9-10mL的去离子水混合,用氨水调节溶液的pH值为10,之后加入碳化钛纳米粉末0.25-0.35g,再用氨水调节溶液的pH值为10,将上述配好的溶液以20000-30000HZ的频率超声30-40min,再搅拌1-2h;
4)碳化钛薄膜样片的制备:把镁合金片和石墨片浸入碳化钛溶液中,分别作为阴极和阳极,施加2.0V电压通电电泳3min后,将阴极镁合金片带电极取出,自然风干后在500-600℃焙烧1h即制得碳化钛薄膜样片;
5)将2-10g的纳米碳晶、30-40mL的乙醇和4-5mL的钛酸四丁酯混合,再加入10mL浓度为20mg/mL的乙酸纤维素混合形成溶胶,旋涂到经步骤4)处理的碳化钛薄膜样片,于450-500℃下煅烧2-3h,即得。
3.如权利要求2所述的所述的表面镀有纳米碳晶膜的人体植入材料的制备方法,其特征在于,步骤1)中,镁合金试样的尺寸为1cm×1cm×0.5cm,酒精浸泡的时间为30-40min,无水乙醇清洗3-4次;步骤3)中搅拌采用磁力搅拌,搅拌的速度为1000-1500rpm。
4.如权利要求2所述的所述的表面镀有纳米碳晶膜的人体植入材料的制备方法,其特征在于,步骤4)中,镁合金片和石墨片的表面积相同,镁合金片和石墨片二者的距离为7-9cm。
5.如权利要求2所述的所述的表面镀有纳米碳晶膜的人体植入材料的制备方法,其特征在于,步骤5)中,先称取纳米碳晶2-10g,加入到30-40mL的乙醇中,再向其中加入4-5mL的钛酸四丁酯。
6.如权利要求2所述的所述的表面镀有纳米碳晶膜的人体植入材料的制备方法,其特征在于,步骤5)中,旋凃采用的旋涂仪参数设置为转速为300-400r/min-60s,加速度为2500-3000r/min-30s。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810763459.5A CN108842119B (zh) | 2018-07-12 | 2018-07-12 | 一种表面镀有纳米碳晶膜的人体植入材料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810763459.5A CN108842119B (zh) | 2018-07-12 | 2018-07-12 | 一种表面镀有纳米碳晶膜的人体植入材料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108842119A true CN108842119A (zh) | 2018-11-20 |
CN108842119B CN108842119B (zh) | 2020-11-13 |
Family
ID=64196996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810763459.5A Active CN108842119B (zh) | 2018-07-12 | 2018-07-12 | 一种表面镀有纳米碳晶膜的人体植入材料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108842119B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06316740A (ja) * | 1992-11-13 | 1994-11-15 | Toyota Motor Corp | 高強度マグネシウム基合金およびその製造方法 |
JP2008238183A (ja) * | 2007-03-26 | 2008-10-09 | Kumamoto Univ | マグネシウム合金の製造方法およびマグネシウム合金 |
CN101468538A (zh) * | 2007-12-24 | 2009-07-01 | 比亚迪股份有限公司 | 一种镀膜材料及其制备方法 |
-
2018
- 2018-07-12 CN CN201810763459.5A patent/CN108842119B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06316740A (ja) * | 1992-11-13 | 1994-11-15 | Toyota Motor Corp | 高強度マグネシウム基合金およびその製造方法 |
JP2008238183A (ja) * | 2007-03-26 | 2008-10-09 | Kumamoto Univ | マグネシウム合金の製造方法およびマグネシウム合金 |
CN101468538A (zh) * | 2007-12-24 | 2009-07-01 | 比亚迪股份有限公司 | 一种镀膜材料及其制备方法 |
Non-Patent Citations (1)
Title |
---|
康进兴等: "《航空材料学》", 31 March 2013, 国防工业出版社 * |
Also Published As
Publication number | Publication date |
---|---|
CN108842119B (zh) | 2020-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Sol–gel deposited TiO2 film on NiTi surgical alloy for biocompatibility improvement | |
JP6821335B2 (ja) | イプシロン酸化鉄とその製造方法、磁性塗料および磁気記録媒体 | |
CN114904054B (zh) | 一种高成骨活性的带电复合膜材料的用途 | |
CN111842086B (zh) | 一种提高镁合金耐腐蚀性和抗菌性的复合涂层制备方法 | |
Chen et al. | The magnetic properties and reversal of Fe–Co nanowire arrays | |
Zhang et al. | Blood compatibility of titanium oxide prepared by ion-beam-enhanced deposition | |
Wieferig et al. | Devitrification reduces beam-induced movement in cryo-EM | |
Vagos et al. | Incorporation of carbon nanotubes in polydimethylsiloxane to control Escherichia coli adhesion | |
US5485804A (en) | Enhanced chemical vapor deposition of diamond and related materials | |
Gojzewski et al. | Magnetosomes on surface: an imaging study approach | |
CN1684785A (zh) | 合金纳米微粒及其制造方法、以及使用合金纳米微粒的磁记录介质 | |
CN108842119A (zh) | 一种表面镀有纳米碳晶膜的人体植入材料及其制备方法 | |
Vijayalakshmi et al. | Development of silica glass coatings on 316L SS and evaluation of its corrosion resistance behavior in Ringer’s solution | |
Guzman et al. | Mechanical behaviour of nitrogen-implanted aluminium alloys | |
CN113181438B (zh) | 一种能自愈合和促骨生长的热敏响应性可吸收骨科器械材料及其制备方法 | |
Ebothé et al. | Surface roughness and morphology of Co-(Fe and Ni) binary alloy electrodeposits studied by atomic force microscopy | |
Kasach et al. | Preparation of Chitosan–Graphite-Like Carbon-Nitride Biocoatings on AZ91 Magnesium Alloy | |
Chen et al. | Fabricating honeycomb titanium by freeze casting and anodizing for biomedical applications | |
CN117286440A (zh) | 一种增材制造镍钛合金的热处理方法及其应用 | |
JPH05279836A (ja) | 鋼材表面へのプラズマ浸炭方法 | |
CN108373153A (zh) | 一种纳米金刚石薄膜及其自组装制备方法 | |
Öztürk et al. | Biofilm formation by Staphylococcus epidermidis on nitrogen ion implanted CoCrMo alloy material | |
Okpalugo et al. | The human micro‐vascular endothelial cells in vitro interaction with atomic‐nitrogen‐doped diamond‐like carbon thin films | |
JPH0812895A (ja) | 磁性体・高分子複合微粒子およびその製法 | |
CN109092648B (zh) | 一种疏水柔性纳米草的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |